Natural killer (NK) lymphocyte ADCC supports anti-viral protection and monoclonal antibody
(mAb) anti-tumor therapies. To predict in vivo ADCC therapeutic responses of different …

… The percent specific release (SR) was calculated using the formula % S R = [ ( E x p e r i
m e n t a l c o u n t s − S p o n t a n e o u s R e l e a s e ) / ( M a x − S p o n t a n e o u s …

… The ohmic side is chosen to be on the z-side and a p-stop structure is employed to isolate
the sense strips. A relatively large thermal noise (600e − ) is observed due to the common-…

NK cell ADCC supports monoclonal antibody anti-tumor therapies. We investigated serial
ADCC and whether it could be predicted by NK phenotypes, including expression of CD16A, …

We have measured the inclusive b→ s γ branching ratio to be (2.32±0.57±0.35)× 10− 4,
where the first error is statistical and the second is systematic. Upper and lower limits on the …

Using the CLEO II detector, we have measured the differential cross sections for exclusive
two-photon production of light pseudoscalar mesons π 0, η, and η′. From our measurements …

We have observed the decays B 0→ K*(892) 0 γ and B−→ K*(892)− γ, which are evidence
for the quark-level process b→ sγ. The average branching fraction is (4.5±1.5±0.9)× 10− 5. …

We have searched for two-body charmless hadronic decays of B mesons. Final states include
ππ, Kπ, and KK with both charged and neutral kaons and pions: πρ, Kρ, and K* π; and Kφ, …

… of 0.27 (95% confidence interval 0.11 to 0.67, P=0.005), an absolute risk reduction of 0.059
and a … of −0.44 (−0.64 to −0.24, P<0.001) and the number of needle redirections by a mean …

We have fully reconstructed decays of both B 0 and B− mesons into final states containing
either D, D*, D**, ψ, ψ’, or χ c 1 mesons. This allows us to obtain new results on many physics …